ergoline has been researched along with Edema* in 3 studies
3 other study(ies) available for ergoline and Edema
| Article | Year |
|---|---|
Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease.
Motor fluctuations constitute a severe complication of chronic levodopa therapy. The addition of dopamine agonists may partially alleviate these responses; however, due to the short half-life of these drugs, several daily doses are required. Cabergoline is a new dopamine agonist with a long half-life and can be given in a single daily dose. Seventeen patients with severe fluctuations were treated with cabergoline, seven of them for > 1 year (up to 39 months). The motor status ameliorated and the percentage of "off" hours significantly decreased in the first year and did not increase significantly later during long-term follow-up. Cabergoline is a promising treatment for parkinsonian patients with motor fluctuations. Topics: Aged; Cabergoline; Dopamine Agonists; Drug Tolerance; Dyskinesia, Drug-Induced; Edema; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease | 1995 |
[Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity. II].
Topics: Animals; Behavior, Animal; Central Nervous System; Edema; Electroencephalography; Ergolines; Female; Lysergic Acid Diethylamide; Psychopharmacology; Rats; Serotonin Antagonists; Uterus | 1973 |
Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents.
Topics: Amidines; Animals; Central Nervous System; Cerebral Ventricles; Edema; Ergolines; Foot Diseases; Methysergide; Mice; Plethysmography; Serotonin Antagonists | 1970 |